The NHS introduced an early access treatment programme for Hepatitis C for those with the greatest clinical need. This gave patients with decompensated cirrhosis access to sofosbuvir ahead of it being available in August 2015, as well as other new DAAs.
Chronology Information
Date:
Chapter/issue
Access to Treatment